Literature DB >> 29471421

Class 3 semaphorins modulate the invasive capacity of rheumatoid arthritis fibroblast-like synoviocytes.

Man Wai Tang1, Beatriz Malvar Fernández1,2, Simon P Newsom1, Jaap D van Buul3, Timothy R D J Radstake2, Dominique L Baeten1, Paul P Tak1,4,5, Kris A Reedquist1,2, Samuel García1,2.   

Abstract

Objective: Class 3 semaphorins regulate diverse cellular processes relevant to the pathology of RA, including immune modulation, angiogenesis, apoptosis and invasive cell migration. Therefore, we analysed the potential role of class 3 semaphorins in the pathology of RA.
Methods: Protein and mRNA expression in RA synovial tissue, SF and fibroblast-like synoviocytes (FLS) were determined by immunoblotting and quantitative PCR (qPCR). RA FLS migration and invasion were determined using wound closure and transwell invasion assays, respectively. PlexinA1, neuropilin-1 and neuropilin-2 expression was knocked down using small interfering RNA (siRNA). Activation of FLS intracellular signalling pathways was assessed by immunoblotting.
Results: mRNA expression of semaphorins (Sema)3B, Sema3C, Sema3F and Sema3G was significantly lower in the synovial tissue of early arthritis patients at baseline who developed persistent disease compared with patients with self-limiting disease after 2 years follow-up. Sema3B and Sema3F expression was significantly lower in arthritis patients fulfilling classification criteria for RA compared with those who did not. FLS expression of Sema3A was induced after stimulation with TNF, IL-1β or lipopolysaccharides (LPS), while Sema3B and Sema3F expression was downregulated. Exogenously applied Sema3A induced the migration and invasive capacity of FLS, while stimulation with Sema3B or Sema3F reduced spontaneous FLS migration, and platelet-derived growth factor induced cell invasion, effects associated with differential regulation of MMP expression and mediated by the PlexinA1 and neuropilin-1 and -2 receptors.
Conclusion: Our data suggest that modulation of class 3 semaphorin signaling could be a novel therapeutic strategy for modulating the invasive behaviour of FLS in RA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29471421     DOI: 10.1093/rheumatology/kex511

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium.

Authors:  Jumpei Shoda; Shigeru Tanaka; Keishi Etori; Koto Hattori; Tadamichi Kasuya; Kei Ikeda; Yuko Maezawa; Akira Suto; Kotaro Suzuki; Junichi Nakamura; Yoshiro Maezawa; Minoru Takemoto; Christer Betsholtz; Koutaro Yokote; Seiji Ohtori; Hiroshi Nakajima
Journal:  Arthritis Res Ther       Date:  2022-06-04       Impact factor: 5.606

Review 2.  Emerging role of semaphorin-3A in autoimmune diseases.

Authors:  Li-Na Liu; Xiao-Mei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammopharmacology       Date:  2018-04-25       Impact factor: 4.473

3.  Soluble neuropilin-1 in gingival crevicular fluid is associated with rheumatoid arthritis: An exploratory case-control study.

Authors:  Diego Prieto; Camila González; Laura Weber; Ornella Realini; Karina Pino-Lagos; Maria José Bendek; Ignacio Retamal; Víctor Beltrán; Juan Pablo Riedemann; Francisco Espinoza; Alejandra Chaparro
Journal:  J Oral Biol Craniofac Res       Date:  2021-02-22

4.  Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.

Authors:  Konrad Dziobek; Marcin Opławski; Beniamin Grabarek; Nikola Zmarzły; Robert Kiełbasiński; Ewa Leśniak; Piotr Januszyk; Krzysztof Januszyk; Iwona Adwent; Dariusz Dąbruś; Przemysław Kieszkowski; Kamil Kiełbasiński; Agnieszka Kuś-Kierach; Dariusz Boroń
Journal:  Curr Pharm Biotechnol       Date:  2019       Impact factor: 2.837

Review 5.  Transformation of fibroblast-like synoviocytes in rheumatoid arthritis; from a friend to foe.

Authors:  Mohammad Javad Mousavi; Jafar Karami; Saeed Aslani; Mohammad Naghi Tahmasebi; Arash Sharafat Vaziri; Ahmadreza Jamshidi; Elham Farhadi; Mahdi Mahmoudi
Journal:  Auto Immun Highlights       Date:  2021-02-05

6.  A genome-wide association study in a large community-based cohort identifies multiple loci associated with susceptibility to bacterial and viral infections.

Authors:  Thomas Tängdén; Stefan Gustafsson; Abhiram S Rao; Erik Ingelsson
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.996

7.  Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis.

Authors:  Ana Igea; Tiago Carvalheiro; Beatriz Malvar-Fernández; Sara Martinez-Ramos; Carlos Rafael-Vidal; Ellis Niemantsverdriet; Jezabel Varadé; Andrea Fernández-Carrera; Norman Jimenez; Trudy McGarry; Angela Rodriguez-Trillo; Douglas Veale; Ursula Fearon; Carmen Conde; Jose M Pego-Reigosa; África González-Fernández; Kris A Reedquist; Timothy R D J Radstake; Annette van der Helm-Van Mil; Samuel García
Journal:  Arthritis Rheumatol       Date:  2022-04-13       Impact factor: 15.483

8.  The association of semaphorins 3C, 5A and 6D with liver fibrosis stage in chronic hepatitis C.

Authors:  Neven Papic; Snjezana Zidovec Lepej; Lana Gorenec; Ivana Grgic; Slavko Gasparov; Tajana Filipec Kanizaj; Adriana Vince
Journal:  PLoS One       Date:  2018-12-28       Impact factor: 3.240

9.  Identification of putative master regulators in rheumatoid arthritis synovial fibroblasts using gene expression data and network inference.

Authors:  Naouel Zerrouk; Quentin Miagoux; Aurelien Dispot; Mohamed Elati; Anna Niarakis
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

10.  Non-Canonical WNT5A Signaling Through RYK Contributes to Aggressive Phenotype of the Rheumatoid Fibroblast-Like Synoviocytes.

Authors:  Angela Rodriguez-Trillo; Nerea Mosquera; Carmen Pena; Fatima Rivas-Tobío; Antonio Mera-Varela; Antonio Gonzalez; Carmen Conde
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.